» Authors » W L Chandler

W L Chandler

Explore the profile of W L Chandler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 611
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chandler W
Int J Lab Hematol . 2013 Mar; 35(3):339-43. PMID: 23480055
Emergency hemostasis testing is typically used to determine which blood products are needed to correct hemostatic defects associated with bleeding. Rapid assessment of hemostasis can be performed using standard or...
2.
Chandler W, Yeung W, Tait J
J Thromb Haemost . 2011 Apr; 9(6):1216-24. PMID: 21481178
Background:  Microparticle size measurements are often calibrated on flow cytometers using polystyrene microspheres that forward scatter more light vs. particle diameter than cellular microparticles. Methods:  We compared theoretical with measured...
3.
Vigen C, Hodis H, Chandler W, Lobo R, Mack W
J Thromb Haemost . 2007 Mar; 5(6):1201-8. PMID: 17389005
Background: Hemostatic factors influenced by postmenopausal hormone therapy may contribute to atherosclerosis. The Estrogen in the Prevention of Atherosclerosis Trial (EPAT), a 2-year, randomized, double-blind, placebo-controlled trial, demonstrated reduced subclinical...
4.
Reiner A, Carlson C, Rieder M, Siscovick D, Liu K, Chandler W, et al.
J Thromb Haemost . 2006 Oct; 5(1):42-9. PMID: 17059418
Background: Associations between common F7 haplotypes, plasma factor VII (FVII) levels, and cardiovascular risk have recently been reported in population studies involving predominantly European men. Methods: We assessed associations between...
5.
Austin M, Zhang C, Humphries S, Chandler W, Talmud P, Edwards K, et al.
Ann Hum Genet . 2004 Jun; 68(Pt 3):179-88. PMID: 15180698
Numerous studies have demonstrated that increased C-reactive protein (CRP) levels predict coronary heart disease, stroke, peripheral vascular disease, and diabetes, and are associated with features of the metabolic syndrome. Only...
6.
Poliachik S, Chandler W, Mourad P, Ollos R, Crum L
Ultrasound Med Biol . 2001 Dec; 27(11):1567-76. PMID: 11750756
Using platelet-rich plasma, we investigated the effect of 1.1-MHz continuous wave high-intensity focused ultrasound (HIFU) on platelet activation, aggregation and adhesion to a collagen-coated surface. Platelets were exposed for durations...
7.
Sprouse J, Wong C, Chandler W, Williams G, Watkins S, Tarr P
Blood Coagul Fibrinolysis . 2001 Jul; 12(4):283-8. PMID: 11460012
Hemolytic uremic syndrome (HUS) of childhood most commonly follows gastrointestinal infection with Escherichia coli O157:H7. This pathogen elaborates Shiga toxins that are believed to cause microvascular injury and to trigger...
8.
Nicholls S, Chandler W, Hoffer E
Br J Haematol . 2001 May; 113(2):559-60. PMID: 11380434
No abstract available.
9.
Tsai H, Chandler W, Sarode R, Hoffman R, Jelacic S, Habeeb R, et al.
Pediatr Res . 2001 May; 49(5):653-9. PMID: 11328948
Hemolytic uremic syndrome (HUS) usually occurs after infection with Shiga toxin-producing bacteria. Thrombotic thrombocytopenic purpura, a disorder with similar clinical manifestations, is associated with deficient activity of a circulating metalloprotease...
10.
Chandler W, Patel M, Gravelle L, Soltow L, Lewis K, Bishop P, et al.
Blood Coagul Fibrinolysis . 2001 Apr; 12(2):101-8. PMID: 11302471
Reduced factor XIIIA levels and decreased clot strength have been associated with increased bleeding after cardiopulmonary bypass (CPB). The purpose of this study was to evaluate the relationship between hemostatic...